News and Events
UCL announces the launch of gene therapy company Athena Vision
24 November 2015
Athena Vision is focused on developing gene therapies for eye
diseases based on research conducted at UCL.
UCL Business PLC, the wholly-owned technology transfer
company of UCL, today announced the formation of Athena Vision Limited, a
biopharmaceutical company focused on the development of gene therapies to treat
a range of devastating eye diseases causing blindness.
Poorer dementia patients in England less likely to be prescribed drugs
19 November 2015
Dementia patients from more affluent areas in England are 27% more likely
to be prescribed anti-dementia drugs than patients from poorer areas, finds a
new UCL study of 77,045 dementia patients across the UK. This inequality was
not seen in Scotland, Northern Ireland or Wales.
Developing molecular diagnostics for pneumonia in hospitals
18 November 2015
Clinicians and scientists from UCLH, UCL
and the University of East Anglia (UEA) have been awarded a £2.5 million grant
by the National Institute for Health Research to develop and evaluate new
molecular diagnostic tests.
Changes in humour an early sign of dementia
10 November 2015
Researchers at UCL have revealed that a change
in sense of humour could be an early sign of dementia. The findings could help
improve dementia diagnosis, by highlighting changes not commonly thought to be
linked to the condition.
UCL professor is first UK winner of $3m Breakthrough Prize in Life Sciences
9 November 2015
Professor John Hardy (UCL Institute of Neurology) was last night awarded
the $3 million Breakthrough Prize in Life Sciences for his pioneering research
into the genetic causes of Alzheimer’s disease, other forms of dementia and
Search UCL News
Support us | Vacancies and fellowships | Contact SLMS | IT for SLMS